Pharmaxis Ltd operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pharmaxis Ltd with three other
companies in this sector in Australia:
Benitec Biopharma Limited
sales of 16.60 million Australian Dollars [US$11.46 million]
(7.47 million Australian Dollars [US$5.15 million]
Idt Australia Limited.
(12.13 million Australian Dollars [US$8.37 million]
Sales fell dramatically in 2019:
During the year ended June of 2019, sales at
Pharmaxis Ltd were A$12.55 million (US$8.66 million).
decrease of 75.1%
versus 2018, when the company's sales were A$50.33 million.